bioRxivPharmacology & Toxicology
Perfluorooctanoic acid activates multiple nuclear receptor pathways and skews expression of genes regulating cholesterol homeostasis in liver of humanized PPARα mice fed an American diet
J. Schlezinger, H. Puckett, J. Oliver, G. Nielsen, W. Heiger-Bernays, T. Webster
Abstract
Humans are exposed to per- and polyfluoroalkyl substances (PFAS) in their drinking water, food, air, dust in their homes, and by direct use of consumer products. Increased concentrations of serum total cholesterol and low density lipoprotein cholesterol are among the endpoints best supported by epidemiology. The objectives of this study were to generate a new model for examining PFAS-induced dyslipidemia and to conduct molecular studies to better define mechanism(s) of action. We tested the hypothesis that PFOA exposure at a human-relevant level dysregulates expression of genes controlling cholesterol homeostasis in livers of mice expressing human PPAR (hPPAR). Female and male hPPAR and PPAR null mice were fed a diet based on the "What we eat in America" analysis and exposed to perfluorooctanoic acid (PFOA) in drinking water (8 {micro}M) for 6 weeks. This resulted in a serum PFOA concentration of 48 g/ml. PFOA increased liver mass, which was associated with histologically-evident lipid accumulation. PFOA induced PPAR and constitutive androstane receptor target gene expression in liver. Expression of genes in four pathways regulating cholesterol homeostasis were also measured. PFOA decreased expression of Hmgcr in a PPAR-dependent manner. PFOA decreased expression of Ldlr and Cyp7a1 in a PPAR-independent manner. Apob expression was not changed. Gene expression in females appeared to be more sensitive to PFOA exposure than in males. This novel study design (hPPAR mice, American diet, long term exposure) generated new insight on the effects of PFOA on cholesterol regulation in the liver and the role of hPPAR.
- organism: mouse
- assay: bulk RNA-seq
- research focus: gene regulatory network inference
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Perfluorooctanoic Acid Induces Liver and Serum Dyslipidemia in Humanized PPARα Mice Fed an American Diet
J. J. Schlezinger, T. Hyotylainen, … T. F. Webster·bioRxiv·Apr 3, 2021
- Identifying Human Specific Adverse Outcome Pathways of Per- and Polyfluoroalkyl Substances Using Liver-Chimeric Humanized Mice
D. R. Robarts, D. Paine-Cabrera, … U. Apte·bioRxiv·Feb 1, 2023
- PPARα genotype impacts bone quality and perfluorooctanoic acid-induced effects
Maribel Carpenter, Jennifer J. Schlezinger·bioRxiv·Oct 31, 2026
- Trifluoroacetate reduces plasma lipid levels and the development of atherosclerosis in mice
Wei Tang, Audrey S. Black, … M. Reza Ghadiri·bioRxiv·Mar 6, 2025
- Investigating the mode of action for liver toxicity and wasting-like responses produced by high dose exposures to longer chain perfluoroacid substances (PFAS) using high throughput transcriptomics
R. Barutcu, M. Black, M. E. Andersen·bioRxiv·Mar 2, 2024
- Oral exposure to Perfluorooctanoic acid disrupts the microbiota-gut-liver axis and enhances the severity of chemically induced colitis in mice.
Jungjae Park, Alessandra S. Miller, … Mélanie G. Gareau·Environmental PollutionPeer-reviewed·Aug 6, 2026